Envestnet Asset Management Inc. Decreases Stake in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)
Envestnet Asset Management Inc. reduced its position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Free Report) by 78.9% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 306,254 shares of the pharmaceutical company’s stock after selling 1,145,620 shares during the period. Envestnet Asset […]
More Stories
ANyONe Protocol (ANYONE) Price Tops $0.83 on Major Exchanges
ANyONe Protocol (ANYONE) traded 5.4% lower against the dollar during the 24 hour period ending at 16:00 PM ET on...
Bitcoiva Reaches 24-Hour Volume of $271,003.18 (BCA)
Bitcoiva (BCA) traded 5% lower against the US dollar during the 1-day period ending at 16:00 PM Eastern on October...
ALL BEST ICO Price Up 96.9% Over Last Week (ALLBI)
ALL BEST ICO (ALLBI) traded down 95.5% against the US dollar during the 24 hour period ending at 16:00 PM...
Rep. Marjorie Taylor Greene Buys Caterpillar Inc. (NYSE:CAT) Stock
Representative Marjorie Taylor Greene (R-Georgia) recently bought shares of Caterpillar Inc. (NYSE:CAT). In a filing disclosed on October 22nd, the...
Tango Therapeutics (NASDAQ:TNGX) Sets New 52-Week Low – Should You Sell?
Tango Therapeutics, Inc. (NASDAQ:TNGX – Get Free Report)’s share price hit a new 52-week low on Wednesday . The company...
Focusrite (LON:TUNE) Reaches New 52-Week Low – Here’s Why
Focusrite plc (LON:TUNE – Get Free Report)’s share price hit a new 52-week low during mid-day trading on Wednesday ....